News
RMTI
8.10
+6.02%
0.46
Rockwell Medical Maintained at Buy as Operational Progress and Discounted Valuation Support Upside Despite Cut to $20 Price Target
TipRanks · 2d ago
Weekly Report: what happened at RMTI last week (0810-0814)?
Weekly Report · 5d ago
Rockwell Medical reports Q2 EPS (4c) vs. (7c) last year
TipRanks · 5d ago
Rockwell Medical sees 2026 revenue $70.0M-$75.0M vs. $69.26M in 2025
TipRanks · 5d ago
Rockwell Medical Earnings Call Signals Building Momentum
TipRanks · 6d ago
Rockwell Medical Releases Updated Investor Corporate Presentation
TipRanks · 08/13 11:58
Rockwell Medical (RMTI) Reports Q2 Loss, Lags Revenue Estimates
NASDAQ · 08/13 11:10
Rockwell Medical Non-GAAP EPS of -$0.04, revenue of $17.78M misses by $0.06M
Seeking Alpha · 08/13 10:08
Press Release: Rockwell Medical Announces Second Quarter 2026 Results
Dow Jones · 08/13 10:03
Press Release: Rockwell Medical Announces Second -3-
Dow Jones · 08/13 10:03
*Rockwell Medical Backs 2026 Sales $70M-$75M >RMTI
Dow Jones · 08/13 10:02
Rockwell Medical Q2 Adj. EPS $(0.04) Beats $(0.23) Estimate, Sales $17.780M Miss $17.837M Estimate
Benzinga · 08/13 10:01
Rockwell Medical Affirms FY2026 Sales Guidance of $70.000M-$75.000M vs $72.469M Est
Benzinga · 08/13 10:01
*Rockwell Medical 2Q Adj Loss/Shr 4c >RMTI
Dow Jones · 08/13 10:01
*Rockwell Medical 2Q Loss/Shr 34c >RMTI
Dow Jones · 08/13 10:00
*Rockwell Medical 2Q Sales $17.8M >RMTI
Dow Jones · 08/13 10:00
Rockwell Medical: Q2 Earnings Snapshot
Barchart · 08/13 05:04
Rockwell Medical Q2 Earnings Preview
Seeking Alpha · 08/12 16:00
Village Farms (VFF) Q2 Earnings and Revenues Beat Estimates
NASDAQ · 08/10 12:15
Weekly Report: what happened at RMTI last week (0803-0807)?
Weekly Report · 08/10 09:00
More
Webull provides a variety of real-time RMTI stock news. You can receive the latest news about Rockwell Med Inc through multiple platforms. This information may help you make smarter investment decisions.
About RMTI
Rockwell Medical, Inc. is a healthcare company. The Company develops, manufactures, commercializes, and distributes a portfolio of hemodialysis products for dialysis providers worldwide. The Company operates in the hemodialysis market, which involves the manufacture, sale and distribution of hemodialysis products to hemodialysis clinics, including pharmaceuticals, dialysis concentrates, dialysis kits and other ancillary products used in the dialysis process. Its hemodialysis concentrates products are used to sustain a patient's life by removing toxins and balancing electrolytes in a dialysis patient’s bloodstream. The Company is the supplier of liquid and dry, acid and bicarbonate concentrates for dialysis patients in the United States. The Company manufactures hemodialysis concentrates at its facilities in Michigan, South Carolina, and Texas, and the Company manufactures its dry acid concentrate mixers at its facility in Iowa.